In vivo action of IL-27: Reciprocal regulation of Th17 and treg cells in collagen-induced arthritis

Experimental and Molecular Medicine

Volumn 45, Issue 10, 2013, Pages

  Moon, Su Jin ^a   Park, Jin Sil ^b   Heo, Yu Jung ^b   Kang, Chang Min ^b   Kim, Eun Kyung ^b   Lim, Mi Ae ^b   Ryu, Jun Geol ^b   Park, Seong Jeong ^c   Park, Kyung Su ^b   Sung, Young Chul ^c   Park, Sung Hwan ^b   Kim, Ho Youn ^b   Min, Jun Ki ^a   Cho, Mi La ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

collagen induced arthritis; interleukin 17 producing T cells; interleukin 27; regulatory T cells; rheumatoid arthritis

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 27; PROGRAMMED DEATH 1 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; IL27 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL; UPREGULATION; ANIMAL; ARTHRITIS, EXPERIMENTAL; C57BL MOUSE; CELL CULTURE; DBA MOUSE; IMMUNOLOGY; EXPERIMENTAL ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; HUMANS; INTERLEUKINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84892421982     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.89     Document Type: Article

References (51)

1. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(\+) T cells. Immunity 2002; 16: 779-790.
2. Villarino AV, Huang E, Hunter CA. Understanding the pro-and antiinflammatory properties of IL-27. J Immunol 2004; 173: 715-720.
3. Wojno ED, Hosken N, Stumhofer JS, O'Hara AC, Mauldin E, Fang Q et al. A role for IL-27 in limiting T regulatory cell populations. J Immunol 2011; 187: 266-273.
4. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003; 170: 4886-4890.
5. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 2006; 176: 237-247.
6. Hu Y, Cheng W, Cai W, Yue Y, Li J, Zhang P. Advances in research on animal models of rheumatoid arthritis. Clin Rheumatol 2012; 32: 161-165.
7. Partsch G, Steiner G, Leeb BF, Dunky A, Broll H, Smolen JS. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 1997; 24: 518-523.
8. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A et al. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 202-213.
9. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008; 67: 1474-1479.
10. Wong CK, Chen da P, Tam LS, Li EK, Yin YB, Lam CW. Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12: R129.
11. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007; 204: 2803-2812.
12. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 2003; 100: 5986-5990.
13. Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173: 1171-1178.
14. Park JS, Jung YO, Oh HJ, Park SJ, Heo YJ, Kang CM et al. Interleukin-27 suppresses osteoclastogenesis via induction of interferon-gamma. Immunology 2012; 137: 326-335.
15. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide- induced septic shock and allogeneic islet transplantation. J Immunol 1995; 154: 5590-5600.
16. Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, Sung YC et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Therapy 2003; 10: 1592-1599.
17. Bettan M, Emmanuel F, Darteil R, Caillaud JM, Soubrier F, Delaere P et al. High-level protein secretion into blood circulation after electric pulsemediated gene transfer into skeletal muscle. Mol Ther 2000; 2: 204-210.
18. Park MK, Park JS, Cho ML, Oh HJ, Heo YJ, Woo YJ et al. Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(\+) regulatory and IL-17(\+) pathogenic T cell in autoimmune arthritis. Immunol Lett 2011; 135: 50-58.
19. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z et al. CTLA-4 control over Foxp3\+ regulatory T cell function. Science 2008; 322: 271-275.
20. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206: 3015-3029.
21. Schaer DA, Murphy JT, Wolchok JD. Modulation of GITR for cancer immunotherapy. Curr Opin Immunol 2012; 24: 217-224.
22. Pickens SR, Chamberlain ND, Volin MV, Mandelin AM II, Agrawal H, Matsui M et al. Local expression of interleukin-27 ameliorates collageninduced arthritis. Arthritis Rheum 2011; 63: 2289-2298.
23. Park JS, Jung YO, Oh HJ, Park SJ, Heo YJ, Kang CM et al. Interleukin-27 suppresses osteoclastogenesis via induction of interferon-gamma. Immunology 2012; 137: 326-335.
24. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006; 7: 937-945.
25. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7: 929-936.
26. Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 2012; 37: 511-523.
27. Shibata S, Tada Y, Asano Y, Yanaba K, Sugaya M, Kadono T et al. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions. J Invest Dermatol 2013; 133: 479-488.
28. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240.
29. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al. Interleukin 17-producing CD4\+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
30. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
31. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-646.
32. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454: 350-352.
33. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9: 641-649.
34. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 2008; 41: 84-91.
35. Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 2005; 7: 29-37.
36. Waldburger JM, Firestein GS. Garden of therapeutic delights: new targets in rheumatic diseases. Arthritis Res Ther 2009; 11: 206.
37. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK et al. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 2001; 167: 1004-1013.
38. Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010; 62: 929-939.
39. Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases. Curr Opin Immunol 2000; 12: 684-690.
40. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ et al. CD25\+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003; 48: 1452-1460.
41. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4\+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215-223.
42. Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O. CD4\+ CD25\+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140: 360-367.
43. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200: 277-285.
44. Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci USA 2008; 105: 19396-19401.
45. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007; 204: 33-39.
46. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE. TNF downmodulates the function of human CD4\+CD25hi T-regulatory cells. Blood 2006; 108: 253-261.
47. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(\+)CD4(\+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
48. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(\+)CD4(\+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3: 135-142.
49. Bodhankar S, Vandenbark AA, Offner H. Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17beta-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4\+ Foxp3\+ regulatory T cells. Immunology 2012; 137: 282-293.
50. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-151.
51. Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Distinct roles of CTLA-4 and TGF-beta in CD4\+CD25\+ regulatory T cell function. Eur J Immunol 2004; 34: 2996-3005.